biogen stock jumped on wednesday after a south korean newspaper reported that samsung group was in talks to acquire the drugmaker a samsung spokesperson told barron’s in an emailed statement that the report was groundless the korea economic daily citing unnamed investment banking sources reported that samsung is engaged in negotiations